Novavax CEO: 'Burden's on us' to convince FDA on UK data

Novavax is on the cusp of getting approval for its Covid-19 vaccine.

CEO Stanley Erck says proving to the FDA that the UK trial data is comparable could get the vaccine into the US faster.